Smith-Vaughan, Heidi C.
Binks, Michael J.
Beissbarth, Jemima
Chang, Anne B.
McCallum, Gabrielle B.
Mackay, Ian M.
Morris, Peter S.
Marsh, Robyn L.
Torzillo, Paul J.
Wurzel, Danielle F.
Grimwood, Keith
Nosworthy, Elizabeth
Gaydon, Jane E.
Leach, Amanda J.
MacHunter, Barbara
Chatfield, Mark D.
Sloots, Theo P.
Cheng, Allen C.
Funding for this research was provided by:
National Health and Medical Research Council (GNT1023781)
Article History
Received: 29 March 2018
Accepted: 21 June 2018
First Online: 29 June 2018
Compliance with ethical standards
:
: AJL and PSM received research grant funding from Wyeth (now Pfizer) for one of the original studies from which data for this analysis were derived. AJL currently receives research grant funding from GlaxoSmithKline to support infrastructure costs of pneumococcal conjugate vaccine research in remote areas (the OUTREACH project). These both are considered to be low conflicts of interest. HSV, ABC, and KG received funding from the NHMRC (Australia) related to this study; this is not considered a conflict of interest.
: The Human Research Ethics Committees of the NT Department of Health and Menzies School of Health Research (2011-1668) approved this retrospective study.
: Written informed consent was obtained in the original studies. In the original studies all procedures involving human participants were in accordance with the ethical standards of the institutional human research ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The results of this study were presented at the 10th International Symposium on Pneumococci and Pneumococcal Diseases in Glasgow, Scotland, 26–30 June, 2016.